Clinical Research Directory
Browse clinical research sites, groups, and studies.
Peripheral Drivers of Heart Failure Progression - the Prospective PEDAL-HF Study
Sponsor: University of Leipzig
Summary
PEDAL-HF is a registry-based randomized prospective multicenter study. We plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be randomized to care within a heart failure network or usual care. The primary endpoint of the randomized trial is change in NT-proBNP from baseline to 6 months of follow-up. All patients (randomized or not) will be followed for two years.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2024-11-01
Completion Date
2028-12-31
Last Updated
2024-10-24
Healthy Volunteers
No
Conditions
Interventions
Heart Failure network care
Patients will receive three visits within the first three months after randomization for improving heart failure therapy at a cardiologist or the outpatient heart failure clinic